Reply to Torgrim Tandstad. The New Standard Adjuvant Treatment for High-risk Stage 1 Nonseminoma: Reducing the Treatment Burden and Maximizing Long-term Survival. Eur Urol 2020;77:352-3.

Huddart, Robert, Joffe, Johnathan and Cullen, Michael (2020) Reply to Torgrim Tandstad. The New Standard Adjuvant Treatment for High-risk Stage 1 Nonseminoma: Reducing the Treatment Burden and Maximizing Long-term Survival. Eur Urol 2020;77:352-3. European urology. ISSN 1873-7560.

Full text not available from this repository.
Official URL: https://www.europeanurology.com/article/S0302-2838...
Item Type: Article
Subjects: QZ Pathology. Oncology
Divisions: Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Mrs Yolande Brookes
Date Deposited: 19 Jun 2020 14:46
Last Modified: 19 Jun 2020 14:46
URI: http://www.repository.uhblibrary.co.uk/id/eprint/3190

Actions (login required)

View Item View Item